Diabetes

Novo Nordisk and the FDA announced approval of a new indication for semaglutide 2.4 mg for reduction of risk for major adverse cardiovascular events in adults with overweight or obesity and established CVD.

The FDA cleared for marketing an over-the-counter continuous glucose monitor for adults with or without diabetes, according to an agency press release.

Among pregnant women with type 1 diabetes, more time in optimal glucose range at 12 weeks gestation was associated with lower risks for preeclampsia and large for gestational age infants, researchers reported.

Adults with osteoporosis who received a full course of denosumab were less likely to develop incident diabetes than those who discontinued denosumab after the initial dose, according to study data published in JAMA Network Open.

Shorter sleep durations increased the risk for developing type 2 diabetes, even among those with healthy eating habits, research showed.

Chronic kidney disease stage G3 may be linked with considerable morbidity in a community-based setting, which shows a need for optimized early interventions, according to published data.

Diabetes mellitus may modify the link between chronic kidney disease-mineral and bone disorder biomarkers and aortic stiffness in adults on peritoneal dialysis, according to recently published data.

The FDA issued a warning to people with diabetes not to use smartwatches or smart rings that do not pierce the skin for measuring blood glucose because the readings could be inaccurate.